THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Woodline Partners LP's Holding History (CIK: 0001784547)

Note: Option positions (PUT/CALL) are excluded.

Q3 2022

Shares 119,854 Value ($000) $1,215 Avg Close $9.37 Range $7.53 - $11.00

Q2 2022

Shares 2,243,473 Value ($000) $20,326 Avg Close $9.21 Range $8.15 - $10.52

Q1 2022

Shares 1,326,653 Value ($000) $12,683 Avg Close $9.80 Range $7.71 - $13.17

Q4 2021

Shares 575,113 Value ($000) $6,355 Avg Close $8.72 Range $7.30 - $11.24

Q3 2021

Shares 1,979,130 Value ($000) $14,646 Avg Close $11.19 Range $6.10 - $15.01

Q2 2021

Shares 374,912 Value ($000) $5,444 Avg Close $18.78 Range $14.46 - $22.74

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2022	119,854	$1,215	$9.37	$7.53 - $11.00
Q2 2022	2,243,473	$20,326	$9.21	$8.15 - $10.52
Q1 2022	1,326,653	$12,683	$9.80	$7.71 - $13.17
Q4 2021	575,113	$6,355	$8.72	$7.30 - $11.24
Q3 2021	1,979,130	$14,646	$11.19	$6.10 - $15.01
Q2 2021	374,912	$5,444	$18.78	$14.46 - $22.74